Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Messina

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Expert Review of Clinical Pharmacology|January 14, 2014
Clinical pharmacology of fentanyl buccal tablet for the treatment of breakthrough painMona Darwish, John Messina
Perspectives in Medicinal Chemistry|July 17, 2010
Fentanyl buccal tablet for the treatment of breakthrough pain: pharmacokinetics of buccal mucosa delivery and clinical efficacyMona Darwish, Ehab Hamed, John Messina
Cancer|April 18, 2009
Fentanyl buccal tablet for the treatment of breakthrough pain in opioid-tolerant patients with chronic cancer pain: A long-term, open-label safety studySharon M Weinstein, John Messina, Fang Xie
Drugs of Today (Barcelona, Spain : 1998)|February 28, 2008
Fentanyl buccal tabletJohn Messina, Mona Darwish, Perry G Fine
Clinical Therapeutics|July 10, 2007
Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled studyDavid M Simpson, John Messina, Fang Xie, et al.
The Clinical Journal of Pain|October 24, 2006
A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancerRussell K Portenoy, Donald Taylor, John Messina, et al.
Pain Practice : the Official Journal of World Institute of Pain|March 17, 2010
Consistent and clinically relevant effects with fentanyl buccal tablet in the treatment of patients receiving maintenance opioid therapy and experiencing cancer-related breakthrough painGiovambattista Zeppetella, John Messina, Fang Xie, et al.
Journal of Opioid Management|October 1, 2011
Effect of fentanyl buccal tablet on pain-related anxiety: a 4-week open-label study among opioid-tolerant patients with chronic and breakthrough painLynn R Webster, John Messina, Fang Xie, et al.
Journal of Pain and Symptom Management|July 3, 2010
Long-term safety and tolerability of fentanyl buccal tablet for the treatment of breakthrough pain in opioid-tolerant patients with chronic pain: an 18-month studyPerry G Fine, John Messina, Fang Xie, et al.
Current Medical Research and Opinion|January 9, 2007
Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled studyRussell K Portenoy, John Messina, Fang Xie, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Expert Review of Clinical Pharmacology|January 14, 2014
Clinical pharmacology of fentanyl buccal tablet for the treatment of breakthrough painMona Darwish, John Messina
Perspectives in Medicinal Chemistry|July 17, 2010
Fentanyl buccal tablet for the treatment of breakthrough pain: pharmacokinetics of buccal mucosa delivery and clinical efficacyMona Darwish, Ehab Hamed, John Messina
Cancer|April 18, 2009
Fentanyl buccal tablet for the treatment of breakthrough pain in opioid-tolerant patients with chronic cancer pain: A long-term, open-label safety studySharon M Weinstein, John Messina, Fang Xie
Drugs of Today (Barcelona, Spain : 1998)|February 28, 2008
Fentanyl buccal tabletJohn Messina, Mona Darwish, Perry G Fine
Clinical Therapeutics|July 10, 2007
Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled studyDavid M Simpson, John Messina, Fang Xie, et al.
The Clinical Journal of Pain|October 24, 2006
A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancerRussell K Portenoy, Donald Taylor, John Messina, et al.
Pain Practice : the Official Journal of World Institute of Pain|March 17, 2010
Consistent and clinically relevant effects with fentanyl buccal tablet in the treatment of patients receiving maintenance opioid therapy and experiencing cancer-related breakthrough painGiovambattista Zeppetella, John Messina, Fang Xie, et al.
Journal of Opioid Management|October 1, 2011
Effect of fentanyl buccal tablet on pain-related anxiety: a 4-week open-label study among opioid-tolerant patients with chronic and breakthrough painLynn R Webster, John Messina, Fang Xie, et al.
Journal of Pain and Symptom Management|July 3, 2010
Long-term safety and tolerability of fentanyl buccal tablet for the treatment of breakthrough pain in opioid-tolerant patients with chronic pain: an 18-month studyPerry G Fine, John Messina, Fang Xie, et al.
Current Medical Research and Opinion|January 9, 2007
Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled studyRussell K Portenoy, John Messina, Fang Xie, et al.
Pageof 3